What should you consider when choosing acute myeloid leukemia (AML) care and treatment? In this webinar, Dr. Eytan Stein will review factors that help guide care decisions for AML, discuss the goals of treatment as well as treatment options available, and share tools for taking an active role in your care.
Dr. Eytan Stein is a hematologist oncologist at Memorial Sloan Kettering Cancer Center and serves as Director of the Program for Drug Development in Leukemia in Division of Hematologic Malignancies. Learn more about Dr. Stein, here.
Watch online Wednesday, Oct 19 at 1 PM Eastern (10 AM PT, 12 PM CT) for a 30-minute webinar.
This webinar will be recorded. If you would like to share the webinar with others, the replay will be available within the next few days. To receive a link to the recording, please register and you will be notified when it’s available.
Thrive AML is brought to you by the Patient Empowerment Network. It is made possible through support from Servier, and generous donations from people like you.